Ticker Symbol: CODX
Co-Diagnostics Inc
$9.77 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001692415
Company Profile
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 4049 S Highland Dr
Website: codiagnostics.com
CEO: Dwight Egan
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.00
Change:
-$0.05
(
-4.76%)
Days Range: $0.99 - $1.05
Beta: 1.11
52wk. High: $3.84
52wk. Low: $0.97
Ytd. Change -63.10%
50 Day Moving Average: $1.10
200 Day Moving Average: $1.24
Shares Outstanding: 30788871
Valuation
Market Cap: 3.1B
PE Ratio: -0.78
EPS (TTM): -1.29
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A